PRKAA1 and malignant colon neoplasm: This phenomenon is not likely to be limited to colon cancer as several other groups have demonstrated a requirement for AMPK or its downstream effects in both prostate and breast cancer and have shown that inhibition of AMPK is detrimental to cancer cells32–36.